The current price of INM is $13.21 — it has decreased by 24.53% since the previous close. Data as of Nov 5, 2026.
INM is down 14.77% over the past week, down 0.68% over the past month and down 23.64% over the past year. The price is above its 200-day moving average of $12.17.
Of the 1 analyst covering InMed Pharmaceuticals Inc., 1 rates it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
InMed Pharmaceuticals Inc. has a market capitalization of $7.26M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, InMed Pharmaceuticals Inc. posted a loss of $0.36 per share against an estimate of -$94.44, beating expectations by 99.62%. Upcoming reports are listed in the earnings calendar.
InMed Pharmaceuticals Inc. has not paid any dividends over the past year.
In the latest trading session INM moved between $12.89 and $15.50, a range of 19.76% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of InMed Pharmaceuticals Inc. shows a sell rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for InMed Pharmaceuticals Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks INM has traded between $5.75 and $23.30. The current price is 43.30% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.